CCI
TRIB

Columbus Circle Investors’s Trinity Biotech TRIB Stock Holding History

Columbus Circle Investors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,049
Closed -$635K – 325
2013
Q4 		$635K Sell
5,049
-11,229
-69% -$1.35M ﹤0.01% 276
2013
Q3 		$1.77M Buy
+16,278
New +$1.59M 0.01% 272

Other funds holding TRIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Columbus Circle Investors's TRIB Position: Q1 2014 in Review

Columbus Circle Investors sold out of Trinity Biotech (TRIB) in Q1 2014, closing a stake of 5,049 shares — an estimated $635K sold.

Columbus Circle Investors first reported a position in TRIB in Q3 2013 and held it in 2 quarters. The position peaked at $1.77M in Q3 2013. 81 funds tracked by Wall St. Rank hold TRIB as of Q1 2014.

  • Columbus Circle Investors reported no remaining Trinity Biotech position as of Q1 2014 after selling out during the quarter.
  • Columbus Circle Investors sold 5,049 Trinity Biotech shares in Q1 2014, an estimated $635K.
  • Columbus Circle Investors first reported a position in Trinity Biotech in Q3 2013 and held it in 2 quarters.
  • Columbus Circle Investors's Trinity Biotech position peaked at $1.77M in Q3 2013.
  • 81 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2014.

Based on Columbus Circle Investors's 13F filing for Q1 2014, filed 24 Apr 2014.